Serge C Harb1, Muhammad Haq2, Kathleen Flood3, Angela Guerrieri3, Wendy Passerell3, Wael A Jaber4, Edward J Miller5. 1. Department of Cardiovascular Imaging, Cleveland Clinic, Cleveland, OH, USA. 2. Department of Internal Medicine, Boston Medical Center and Boston University School of Medicine, Boston, MA, USA. 3. American Society of Nuclear Cardiology, Bethesda, MD, USA. 4. Department of Cardiovascular Imaging, Cleveland Clinic, Cleveland, OH, USA. jaberw@ccf.org. 5. Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.
Abstract
BACKGROUND: Tc99m-pyrophosphate (Tc99m-PYP) scintigraphy has emerged as a diagnostic modality for transthyretin (TTR) cardiac amyloidosis (CA). We sought to examine the variability in test utilization across multiple centers in the US. METHODS: An electronic, web-based survey addressing specifics on Tc-99m PYP imaging was emailed to ASNC members, totaling 2785 recipients. Only one response per institution was allowed. RESULTS: Responses were collected from 101 centers between July 2 and July 27, 2015. Among the respondents, 24% performed Tc-99m PYP specifically for CA diagnosis. The most commonly used dose was 20 mCi (37%) and most centers (35%) imaged 1 hour after injection. Scans were most often interpreted by cardiologists (60%). Quantification of uptake was performed in 57% of institutions with almost half (43%) utilizing the heart-to-contralateral lung (H/CL) ratio. CONCLUSIONS: This national survey shows relatively low penetrance and high variability in Tc99m-PYP scintigraphy for CA diagnosis highlighting the need for standardization.
BACKGROUND:Tc99m-pyrophosphate (Tc99m-PYP) scintigraphy has emerged as a diagnostic modality for transthyretin (TTR) cardiac amyloidosis (CA). We sought to examine the variability in test utilization across multiple centers in the US. METHODS: An electronic, web-based survey addressing specifics on Tc-99m PYP imaging was emailed to ASNC members, totaling 2785 recipients. Only one response per institution was allowed. RESULTS: Responses were collected from 101 centers between July 2 and July 27, 2015. Among the respondents, 24% performed Tc-99m PYP specifically for CA diagnosis. The most commonly used dose was 20 mCi (37%) and most centers (35%) imaged 1 hour after injection. Scans were most often interpreted by cardiologists (60%). Quantification of uptake was performed in 57% of institutions with almost half (43%) utilizing the heart-to-contralateral lung (H/CL) ratio. CONCLUSIONS: This national survey shows relatively low penetrance and high variability in Tc99m-PYP scintigraphy for CA diagnosis highlighting the need for standardization.
Entities:
Keywords:
National survey; Tc99m-pyrophosphate; cardiac amyloidosis
Authors: D R Jacobson; R Pastore; S Pool; S Malendowicz; I Kane; A Shivji; S H Embury; S K Ballas; J N Buxbaum Journal: Hum Genet Date: 1996-08 Impact factor: 4.132
Authors: Esther González-López; Maria Gallego-Delgado; Gonzalo Guzzo-Merello; F Javier de Haro-Del Moral; Marta Cobo-Marcos; Carolina Robles; Belén Bornstein; Clara Salas; Enrique Lara-Pezzi; Luis Alonso-Pulpon; Pablo Garcia-Pavia Journal: Eur Heart J Date: 2015-07-28 Impact factor: 29.983
Authors: Selma F Mohammed; Sultan A Mirzoyev; William D Edwards; Ahmet Dogan; Donna R Grogan; Shannon M Dunlay; Veronique L Roger; Morie A Gertz; Angela Dispenzieri; Steven R Zeldenrust; Margaret M Redfield Journal: JACC Heart Fail Date: 2014-04 Impact factor: 12.035
Authors: Michael N Vranian; Brett W Sperry; Mazen Hanna; Rory Hachamovitch; Asad Ikram; Richard C Brunken; Wael A Jaber Journal: J Nucl Cardiol Date: 2017-01-03 Impact factor: 5.952
Authors: Robert J H Miller; Sebastien Cadet; Darren Mah; Payam Pournazari; Denise Chan; Nowell M Fine; Daniel S Berman; Piotr J Slomka Journal: J Nucl Cardiol Date: 2021-03-10 Impact factor: 5.952
Authors: Julia Ilyushenkova; Svetlana Sazonova; Konstantin Zavadovsky; Roman Batalov; Yuliya Rogovskaya; Yana Anfinogenova; Yurii Lishmanov Journal: Cardiol Res Pract Date: 2020-03-16 Impact factor: 1.866